| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.IJANTIMICAG.2012.02.005 |
| P8608 | Fatcat ID | release_forq3yyuvvdb3dmtwcviccj6fq |
| P698 | PubMed publication ID | 22483324 |
| P50 | author | Genyan Liu | Q79377520 |
| Zhihang Peng | Q93235677 | ||
| P2093 | author name string | Yan Cao | |
| Bing Gu | |||
| Ling Zhuang | |||
| Yongyue Wei | |||
| Shiyang Pan | |||
| Rongbin Yu | |||
| Huimin Qian | |||
| Mingqing Tong | |||
| Lianying Zhao | |||
| P433 | issue | 1 | |
| P304 | page(s) | 9-17 | |
| P577 | publication date | 2012-04-05 | |
| P1433 | published in | International Journal of Antimicrobial Agents | Q15724616 |
| P1476 | title | Comparison of the prevalence and changing resistance to nalidixic acid and ciprofloxacin of Shigella between Europe-America and Asia-Africa from 1998 to 2009 | |
| P478 | volume | 40 |
| Q46289787 | A High Burden of Asymptomatic Gastrointestinal Infections in Traditional Communities in Papua New Guinea. |
| Q47149044 | A Study of prevalence of Shigella species and antimicrobial resistance patterns in paediatric medical center, Ahvaz, Iran |
| Q53186937 | An Immucillin-Based Transition-State-Analogous Inhibitor of tRNA-Guanine Transglycosylase (TGT). |
| Q34386251 | Antibiotic resistance-the need for global solutions |
| Q38286609 | Bacteriophage administration significantly reduces Shigella colonization and shedding by Shigella-challenged mice without deleterious side effects and distortions in the gut microbiota |
| Q41172706 | Bacteriophages are the major drivers of Shigella flexneri serotype 1c genome plasticity: a complete genome analysis. |
| Q40116893 | Characterization of Small-Molecule Scaffolds That Bind to the Shigella Type III Secretion System Protein IpaD. |
| Q37335984 | Characterization of a novel fusion protein from IpaB and IpaD of Shigella spp. and its potential as a pan-Shigella vaccine. |
| Q92368044 | Characterizing Shigella species distribution and antimicrobial susceptibility to ciprofloxacin and nalidixic acid in Latin America between 2000-2015 |
| Q34838791 | Clinical importance and epidemiology of quinolone resistance |
| Q38305664 | Comparison of resistance to third-generation cephalosporins in Shigella between Europe-America and Asia-Africa from 1998 to 2012. |
| Q41546071 | Distribution and antimicrobial resistance of enteric pathogens in Chinese paediatric diarrhoea: a multicentre retrospective study, 2008-2013. |
| Q64073850 | Efficacy and potential of phage therapy against multidrug resistant spp |
| Q34501014 | Epidemic and virulence characteristic of Shigella spp. with extended-spectrum cephalosporin resistance in Xiaoshan District, Hangzhou, China |
| Q37696733 | External Quality Assessment in the Evaluation of Laboratory Performance of Faecal Culture |
| Q55453605 | Guidelines for the treatment of dysentery (shigellosis): a systematic review of the evidence. |
| Q42255166 | High rates of quinolone-resistant strains of Shigella sonnei in HIV-infected MSM. |
| Q41120581 | Importation and domestic transmission of Shigella sonnei resistant to ciprofloxacin - United States, May 2014-February 2015. |
| Q93142857 | In Vitro Activity of 3 Commercial Bacteriophage Cocktails Against Salmonella and Shigella spp. Isolates of Human Origin |
| Q50748937 | Interventions to address deaths from childhood pneumonia and diarrhoea equitably: what works and at what cost? |
| Q37658156 | Introduction and establishment of fluoroquinolone-resistant Shigella sonnei into Bhutan |
| Q49997161 | Laboratory monitoring of bacterial gastroenteric pathogens Salmonella and Shigella in Shanghai, China 2006-2012. |
| Q49387435 | Molecular analysis of multidrug resistance in clinical isolates of Shigella spp. from 2001-2010 in Kolkata, India: role of integrons, plasmids, and topoisomerase mutations |
| Q30368857 | Molecular characterization of Shigella spp. from patients in Gabon 2011-2013. |
| Q64084468 | Mutational convergence acts as a major player in adaptive parallel evolution of Shigella spp |
| Q40542903 | Novel mutations in quinolone resistance-determining regions of gyrA, gyrB, parC and parE in Shigella flexneri clinical isolates from eastern Chinese populations between 2001 and 2011. |
| Q55241660 | Out of Asia: the independent rise and global spread of fluoroquinolone-resistant Shigella. |
| Q64987659 | Plasmids of Shigella flexneri serotype 1c strain Y394 provide advantages to bacteria in the host. |
| Q53695290 | Prevalence and Antibiotics Susceptibility Pattern of Salmonella and Shigella Species among Diarrheal Patients Attending Nekemte Referral Hospital, Oromia, Ethiopia. |
| Q36700457 | Prevalence and trends of aminoglycoside resistance in Shigella worldwide, 1999-2010. |
| Q40661574 | Prevalence, resistance patterns, and characterization of integrons of Shigella flexneri isolated from Jiangsu Province in China, 2001-2011. |
| Q34375210 | Recent advances in understanding enteric pathogenic Escherichia coli. |
| Q57945192 | Recent insights into Shigella |
| Q26774868 | SOS response and its regulation on the fluoroquinolone resistance |
| Q38665950 | Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe. |
| Q37477196 | Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study. |
| Q45842408 | Serotype distribution and characteristics of antimicrobial resistance in Shigella isolated from Henan province, China, 2001-2008. |
| Q33443471 | Sex, drugs and smart phone applications: findings from semistructured interviews with men who have sex with men diagnosed with Shigella flexneri 3a in England and Wales |
| Q36935306 | Shigella Antimicrobial Drug Resistance Mechanisms, 2004-2014. |
| Q41263203 | Shigella flexneri serotype 3a: the rise of a superbug |
| Q49923893 | Shigella phages isolated during a dysentery outbreak reveal uncommon structures and broad species diversity. |
| Q46298819 | Shigella species epidemiology and antimicrobial susceptibility: the implications of emerging azithromycin resistance for guiding treatment, guidelines and breakpoints |
| Q34019305 | Shigella: A Highly Virulent and Elusive Pathogen |
| Q36026230 | Shigellosis in Subjects with Traveler's Diarrhea Versus Domestically Acquired Diarrhea: Implications for Antimicrobial Therapy and Human Immunodeficiency Virus Surveillance |
| Q37451925 | Spatio-temporal trends and risk factors for Shigella from 2001 to 2011 in Jiangsu Province, People's Republic of China |
| Q36660473 | Surveillance of antimicrobial susceptibility patterns among Shigella species isolated in China during the 7-year period of 2005-2011. |
| Q26825840 | The Rising Dominance of Shigella sonnei: An Intercontinental Shift in the Etiology of Bacillary Dysentery |
| Q36839276 | The antimicrobial effect of lactobacillus casei culture supernatant against multiple drug resistant clinical isolates of Shigella sonnei and Shigella flexneri in vitro |
| Q38753453 | The genomic signatures of Shigella evolution, adaptation and geographical spread |
| Q30248484 | The importance of integrons for development and propagation of resistance in Shigella: the case of Latin America |
| Q37256091 | Tracking the establishment of local endemic populations of an emergent enteric pathogen |
| Q35872204 | Travel Destinations and Sexual Behavior as Indicators of Antibiotic Resistant Shigella Strains--Victoria, Australia |
| Q38268512 | Treatment of drug-resistant Shigella infections |
| Q57946228 | Two novel mutations in among isolated from Jiangsu Province of China, 2016 |
Search more.